CYP2D6 Hhal genotype and the neuroleptic malignant syndrome (NMS)

Clinica chimica acta; international journal of clinical chemistry

Volumn 265, Issue 1, 1997, Pages 143-144

  Iwahashi, K ^a   Nakamura, K ^a   Suwaki, H ^a   Tsuneoka, Y ^a   Ichikawa, Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6;

DISEASE PREDISPOSITION; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; LETTER; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

CYTOCHROME P-450 CYP2D6; DISEASE SUSCEPTIBILITY; GENOTYPE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SCHIZOPHRENIA;

EID: 0031559639     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00113-7     Document Type: Letter

References (0)